Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6849267
Compositions useful as inhibitors of ERK
expired -
US 6849739
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6849605
Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
expired -
US 6846928
Compositions useful as inhibitors of protein kinases
expired -
US 6846829
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6841674
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6838474
Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
expired -
US 6833381
TNF-&agr; inhibitors
expired -
US 6825224
Prodrugs of carbamate inhibitors of IMPDH
expired -
US 6825190
Protein kinase inhibitors and uses thereof
expired -
US 6818622
Selective MMP inhibitors having reduced side-effects
expired -
US 6803486
Selective neuronal nitric oxide synthase inhibitors
expired -
US 6803371
Purine inhibitors of protein kinases, G proteins and polymerases
expired -
US 6800626
Inhibitors of p38
expired -
US 6800619
Caspase inhibitors and uses thereof
expired -
US 6794498
Method of eliminating inhibitory/instability regions of mRNA
expired -
US 6794383
Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases
expired -
US 6784195
Pyrazole compositions useful as inhibitors of ERK
expired -
US 6767541
HER-2/neu overexpression abrogates growth inhibitory pathways
expired -
US 6764681
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
expired -
US 6764826
Inhibitors of C-reactive protein induced inflammation
expired -
US 6762179
Thiazole compounds useful as inhibitors of protein kinase
expired -
US 6759535
Inhibitors of p38
expired -
US 6756399
Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents
expired